LifeMD: An Overlooked GLP-1 Beneficiary
LifeMD has evolved through multiple rebrandings, now offering 24/7 virtual primary and urgent care access to patients. The company operates RexMD, a men's telehealth platform, serving around 500,00...
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash divid...
LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial...
LifeMD Shares Decline Even After the Launch of Testosterone Therapy
LFMD expands its men's health services with TestoRx, offering convenient testosterone therapy and alternative treatments for low testosterone via telehealth.
LifeMD: Selling WorkSimpli Could Be A Catalyst
LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth a...
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD Inc. NASDAQ: LFMD is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary...
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Office...
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and Shap...
LifeMD, Inc. (LFMD) Q4 2023 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants Davi...
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.02 per share a year ago.
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. NASDAQ: LFMD is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing with no health insurance required.
LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds
LifeMD is recording strong growth figures on the back of WorkSimpli, its SaaS offering. The company currently sports an 87.62% gross profit margin and generated positive operating cash flow for its...
LifeMD's Revival: The Phoenix Of The Health Industry
LifeMD, Inc.'s share price is soaring, once again. The company's focus on GLP-1 medications integration and primary care services exemplifies its commitment to comprehensive patient care. Its consi...
LifeMD: I'm Buying The Commons And The 11.7% Yielding Preferreds
LifeMD reached positive operating cash flow for the first time during its fiscal 2023 second quarter. This boosted the telehealth company's cash and equivalents position and formed an inflection po...
Insiders Are Betting Big on These 3 Stocks Under $10
Primarily, one reason stands above all the others regarding the incentive behind stocks with insider buying: those who are closest to a particular business would only be buying shares if they belie...
Related Companies